Our Story

Darren Kelly

Entrepeneur In Residence - Melbourne

Darren joined Brandon Capital Partners in 2015.

Darren is the Associate Dean (Innovation and Enterprise, MDHS) at The University of Melbourne, the Director of Innovation and Enterprise at the Centre for Eye Research Australia (CERA) and Director of Biomedical Research in the Department of Medicine, St Vincent’s Hospital, Melbourne, where his research expertise lies in progressing pre-clinical novel interventions and developing experimental models of cardiovascular disease.

Darren is the Founder, Chief Executive Officer and Managing Director of both Certa Therapeutics and OccuRx.  Previously, he was Founder, Chief Executive Officer and director of Fibrotech Therapeutics (acquired by Shire in 2014).  He is also an Advisor to Cincera Therapeutics.

Darren has a Bachelor of Medical Life Science from RMIT University and a Masters of Science and PhD in Translational Medicine from The University of Melbourne.